Singular Genomics Systems, Inc., a pioneering force in the genomics industry, is headquartered in the United States. Founded in 2016, the company has rapidly established itself as a leader in next-generation sequencing (NGS) technology, focusing on innovative solutions for genomic research and clinical applications. With a commitment to advancing precision medicine, Singular Genomics offers unique products such as the G4 sequencer, designed to deliver high-throughput, cost-effective sequencing capabilities. This cutting-edge technology sets the company apart by enabling researchers to conduct complex genomic analyses with unprecedented speed and accuracy. Recognised for its significant contributions to the field, Singular Genomics continues to expand its operational reach, positioning itself as a key player in the global genomics landscape.
How does Singular Genomics Systems, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Singular Genomics Systems, Inc.'s score of 23 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Singular Genomics Systems, Inc., headquartered in the US, currently does not have publicly available data regarding its carbon emissions, as no specific emissions figures have been reported. Additionally, there are no documented reduction targets or climate pledges outlined by the company. This lack of information suggests that Singular Genomics may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the industry increasingly prioritises sustainability, it will be essential for Singular Genomics to establish clear commitments and measurable targets to align with global climate goals.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Singular Genomics Systems, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.